Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
27.11.25
/
50%
€93.00
Target price
27.11.26
€117.12
Performance (%)
-6.99%
Price
30.01.26
€85.00
Summary
This prediction is currently active. With a performance of -6.99%, the BUY prediction for Rhythm Pharmaceuticals by Citigroup_Inc_ is down slightly. This prediction currently runs until 27.11.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -2.299% | -2.299% |
| iShares Core DAX® | -1.432% | 0.000% |
| iShares Nasdaq 100 | -0.386% | -0.595% |
| iShares Nikkei 225® | 1.448% | 5.269% |
| iShares S&P 500 | 0.114% | -0.217% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for RYTM provided by MarketBeat